tradingkey.logo
tradingkey.logo
Suchen

Progyny Inc

PGNY
Zur Watchlist hinzufügen
29.450USD
+0.620+2.15%
Handelsschluss 07/01, 16:00ETKurse um 15 Minuten verzögert
2.31BMarktkapitalisierung
36.51KGV TTM

mehr Informationen über Progyny Inc Unternehmen

Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.

Progyny Inc Informationen

BörsenkürzelPGNY
Name des UnternehmensProgyny Inc
IPO-datumOct 25, 2019
CEOAnevski (Peter)
Anzahl der mitarbeiter675
WertpapierartOrdinary Share
GeschäftsjahresendeOct 25
Addresse1359 Broadway
StadtNEW YORK
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl10018
Telefon12128883124
Websitehttps://www.progyny.com/
BörsenkürzelPGNY
IPO-datumOct 25, 2019
CEOAnevski (Peter)

Führungskräfte von Progyny Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Peter (Pete) Anevski
Mr. Peter (Pete) Anevski
Chief Executive Officer, Director
Chief Executive Officer, Director
617.11K
-0.87%
Mr. Jeffrey Gary (Jeff) Park
Mr. Jeffrey Gary (Jeff) Park
Lead Independent Director
Lead Independent Director
30.62K
+25.88%
Mr. Roger C. Holstein
Mr. Roger C. Holstein
Independent Director
Independent Director
20.70K
+32.81%
Ms. Allison Swartz
Ms. Allison Swartz
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
19.99K
-14.07%
Mr. Lloyd H. Dean
Mr. Lloyd H. Dean
Independent Director
Independent Director
18.49K
+36.73%
Ms. Cheryl M. Scott
Ms. Cheryl M. Scott
Independent Director
Independent Director
13.08K
--
Mr. Kevin K. Gordon
Mr. Kevin K. Gordon
Independent Director
Independent Director
11.27K
-10.95%
Mr. Geoffrey Clapp
Mr. Geoffrey Clapp
Chief Product Officer
Chief Product Officer
5.38K
-15.24%
Mr. David Schlanger
Mr. David Schlanger
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Dr. Norman C. Payson, M.D.
Dr. Norman C. Payson, M.D.
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Peter (Pete) Anevski
Mr. Peter (Pete) Anevski
Chief Executive Officer, Director
Chief Executive Officer, Director
617.11K
-0.87%
Mr. Jeffrey Gary (Jeff) Park
Mr. Jeffrey Gary (Jeff) Park
Lead Independent Director
Lead Independent Director
30.62K
+25.88%
Mr. Roger C. Holstein
Mr. Roger C. Holstein
Independent Director
Independent Director
20.70K
+32.81%
Ms. Allison Swartz
Ms. Allison Swartz
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
19.99K
-14.07%
Mr. Lloyd H. Dean
Mr. Lloyd H. Dean
Independent Director
Independent Director
18.49K
+36.73%
Ms. Cheryl M. Scott
Ms. Cheryl M. Scott
Independent Director
Independent Director
13.08K
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Progyny Inc?

Die fünf größten Anteilseigner von Progyny Inc sind: Mr. Peter (Pete) Anevski

Wie viele Institutionen halten Anteile an Progyny Inc (PGNY)?

Mit Stand vom 2026Q1 halten 790 Institutionen Anteile an Progyny Inc, mit einem Gesamtmarktwert von etwa 88.51M, was 113.05% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -31976779.00 gestiegen.

Was ist die größte Einnahmequelle von Progyny Inc?

Am 2026Q1 erzielte das Geschäft mit Fertility benefits services revenue für Progyny Inc den höchsten Umsatz in Höhe von 830.93M, was 64.48% des Gesamtumsatzes entspricht.